Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-026500

Chief Commercial Officer acquired 9,483 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greco Theresa Chief Commercial Officer 2025-05-15 Grant or award +2,441 53,314 D: show line 1 in the form
Greco Theresa Chief Commercial Officer 2025-05-15 Grant or award +7,042 60,356 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greco Theresa Chief Commercial Officer 2025-05-15 Grant or award · Stock Option +12,133 12,133 D: show line 3 in the form
Loading xslF345X05/wk-form4_1747685039.xml…